Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dombernowsky

Showing results (151-160 of 211) with videos related to

Pageof 22
Sort By:
Ugeskrift for Laeger|September 5, 1988
[Medical treatment of cancer--an elucidating report]P Dombernowsky, H H Hansen, N E Hansen, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials GroupS Gundersen, P Dombernowsky, F Cavalli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolaseL Drivsholm, A Vangsted, T Pallesen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patientsE Bork, M Hansen, P Dombernowsky, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 12, 1998
Steroid metabolism in the hormone dependent MCF-7 human breast carcinoma cell line and its two hormone resistant subpopulations MCF-7/LCC1 and MCF-7/LCC2L Jørgensen, N Brünner, M Spang-Thomsen, et al.
Breast Cancer Research and Treatment|January 1, 1993
Toremifene and tamoxifen in advanced breast cancer--a double-blind cross-over trialL E Stenbygaard, J Herrstedt, J F Thomsen, et al.
Cancer Research|December 1, 1983
Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lungK Osterlind, S Sörenson, H H Hansen, et al.
Sarcoma|June 4, 2008
Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma GroupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 10, 2006
Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapyJ Herrstedt, T C Sigsgaard, H A Nielsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancerD Nielsen, J B Jensen, P Dombernowsky, et al.
Pageof 22

Showing results (151-160 of 211) with videos related to

Sort By:
Pageof 22
Ugeskrift for Laeger|September 5, 1988
[Medical treatment of cancer--an elucidating report]P Dombernowsky, H H Hansen, N E Hansen, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. EORTC Early Clinical Trials GroupS Gundersen, P Dombernowsky, F Cavalli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolaseL Drivsholm, A Vangsted, T Pallesen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patientsE Bork, M Hansen, P Dombernowsky, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 12, 1998
Steroid metabolism in the hormone dependent MCF-7 human breast carcinoma cell line and its two hormone resistant subpopulations MCF-7/LCC1 and MCF-7/LCC2L Jørgensen, N Brünner, M Spang-Thomsen, et al.
Breast Cancer Research and Treatment|January 1, 1993
Toremifene and tamoxifen in advanced breast cancer--a double-blind cross-over trialL E Stenbygaard, J Herrstedt, J F Thomsen, et al.
Cancer Research|December 1, 1983
Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lungK Osterlind, S Sörenson, H H Hansen, et al.
Sarcoma|June 4, 2008
Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma GroupO S Nielsen, P Dombernowsky, H Mouridsen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 10, 2006
Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapyJ Herrstedt, T C Sigsgaard, H A Nielsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancerD Nielsen, J B Jensen, P Dombernowsky, et al.
Pageof 22